Option Care keeps growing

BANNOCKBURN, Ill. – Option Care Health reported revenue of about $1.3 billion for the fourth quarter 2024, an increase of 19.7% compared to the same quarter in 2023.  

Net revenue for the full year 2024 was $4.9 billion, up 16.2% compared to $4.3 billion for the full year 2023. 

“The Option Care Health team’s execution produced solid financial results in the fourth quarter and full year 2024, demonstrating resilience in a dynamic and challenging period, while continuing to place the patient at the center of everything that we do,” said CEO John Rademacher. “I am excited about the road ahead and the opportunity to leverage our capabilities to provide more patients high quality, affordable care, in a setting in which they wish to receive it.” 

Gross profit for the fourth quarter was $268.4 million, or 19.9% of net revenue, up 8.6% compared to $247.1 million, or 22% of net revenue, in the fourth quarter of 2023. Adjusted EBITDA for the fourth quarter was $121.6 million, up 8.9% compared to $111.6 million in the fourth quarter of 2023. 

Gross profit for the full year 2024 was about $1 billion, or 20.3% of revenue, up 3.2% compared to $981.2 million, or 22.8% of revenue, in full year 2023. Adjusted EBITDA for full year 2024 was $443.8 million, up 4.4% compared to $425.2 million in full year 2023. 

Also during the fourth quarter, Option Care repurchased approximately $90 million of stock.  

For the full year 2025, Option Care Health expects to deliver the following financial results: 

• Net revenue of $5.3 billion to $5.5 billion 

• Adjusted diluted earnings per share of $1.59 to $1.69 

• Adjusted EBITDA of $450 million to $470 million 

• Cash flow from operations of at least $320 million 

• Effective tax rate of 25% - 27% 

• Net interest expense of approximately $55 million to $60 million